关注
Sanjiv J. Shah
Sanjiv J. Shah
Northwestern University Feinberg School of Medicine
在 northwestern.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Spironolactone for heart failure with preserved ejection fraction
B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ...
New England Journal of Medicine 370 (15), 1383-1392, 2014
26802014
Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy
MS Maurer, JH Schwartz, B Gundapaneni, PM Elliott, G Merlini, ...
New England Journal of Medicine 379 (11), 1007-1016, 2018
20982018
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
New England Journal of Medicine 381 (17), 1609-1620, 2019
19142019
Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans
Journal of British Surgery 107 (11), 1440-1449, 2020
15232020
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction
SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ...
New England Journal of Medicine 387 (12), 1089-1098, 2022
14992022
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
Nature genetics 46 (3), 234-244, 2014
10132014
Phenomapping for novel classification of heart failure with preserved ejection fraction
SJ Shah, DH Katz, S Selvaraj, MA Burke, CW Yancy, M Gheorghiade, ...
Circulation 131 (3), 269-279, 2015
9892015
Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap
SJ Shah, DW Kitzman, BA Borlaug, L Van Heerebeek, MR Zile, DA Kass, ...
Circulation 134 (1), 73-90, 2016
9732016
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ...
Circulation 131 (1), 34-42, 2015
9702015
Fully automated echocardiogram interpretation in clinical practice: feasibility and diagnostic accuracy
J Zhang, S Gajjala, P Agrawal, GH Tison, LA Hallock, L Beussink-Nelson, ...
Circulation 138 (16), 1623-1635, 2018
7762018
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of …
S Dorbala, Y Ando, S Bokhari, A Dispenzieri, RH Falk, VA Ferrari, ...
Circulation: Cardiovascular Imaging 14 (7), e000029, 2021
663*2021
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label …
RK Burt, SJ Shah, K Dill, T Grant, M Gheorghiade, J Schroeder, R Craig, ...
The Lancet 378 (9790), 498-506, 2011
6182011
Isosorbide mononitrate in heart failure with preserved ejection fraction
MM Redfield, KJ Anstrom, JA Levine, GA Koepp, BA Borlaug, HH Chen, ...
New England Journal of Medicine 373 (24), 2314-2324, 2015
5902015
A USA-based registry for pulmonary arterial hypertension: 1982–2006
T Thenappan, SJ Shah, S Rich, M Gomberg-Maitland
European Respiratory Journal 30 (6), 1103-1110, 2007
5872007
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
SD Solomon, B Claggett, EF Lewis, A Desai, I Anand, NK Sweitzer, ...
European heart journal 37 (5), 455-462, 2016
5632016
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
M Vaduganathan, KF Docherty, BL Claggett, PS Jhund, RA de Boer, ...
The Lancet 400 (10354), 757-767, 2022
5442022
Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries
BJA: British Journal of Anaesthesia 117 (5), 601-609, 2016
5402016
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
T Thenappan, SJ Shah, S Rich, L Tian, SL Archer, M Gomberg-Maitland
European Respiratory Journal 35 (5), 1079-1087, 2010
5352010
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
SJ Shah, CSP Lam, S Svedlund, A Saraste, C Hage, RS Tan, ...
European heart journal 39 (37), 3439-3450, 2018
5022018
PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
N Engl J Med 381 (17), 1609-1620, 2019
5012019
系统目前无法执行此操作,请稍后再试。
文章 1–20